Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma

被引：0
|
作者：
Yen-Hao Chen
Ching-Hua Tsai
Yen-Yang Chen
Chih-Chi Wang
Jing-Houng Wang
Chao-Hung Hung
Yuan-Hung Kuo
机构：
[1] Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,Division of Hematology
[2] Chang Gung University,Oncology, Department of Internal Medicine
[3] Chung Shan Medical University,School of Medicine, College of Medicine
[4] Fooyin University,School of Medicine
[5] Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,Department of nursing, School of nursing
[6] Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,Division of Trauma Surgery, Department of Surgery
[7] Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,Division of General Surgery, Department of Surgery
来源：
BMC Cancer | / 23卷
关键词：
Hepatocellular carcinoma; Pembrolizumab; Nivolumab; Immunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
    Chen, Yen-Hao
    Tsai, Ching-Hua
    Chen, Yen-Yang
    Wang, Chih-Chi
    Wang, Jing-Houng
    Hung, Chao-Hung
    Kuo, Yuan-Hung
    BMC CANCER, 2023, 23 (01)
  • [2] Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma
    Kuo, Hsin-Yu
    Han, Meng-Zhi
    Liao, Chih-Hsiang
    Lin, Yih-Jyh
    Wang, Chung-Teng
    Chen, Shang-Hung
    Chang, Ting-Tsung
    Chen, Po-Jun
    Lin, Sheng-Hsiang
    Chen, Chiung-Yu
    Chuang, Chiao-Hsiung
    Wu, I-Chin
    Wu, Juei-Seng
    Hong, Tzu-Chun
    Hsieh, Ming-Tsung
    Lee, Yang-Cheng
    Wu, Hung-Tsung
    Tsai, Hong-Ming
    PHARMACEUTICS, 2022, 14 (11)
  • [3] Real-world data on nivolumab treatment in Asian patients with advanced hepatocellular carcinoma
    Yoon, S. E.
    Hur, J. Y.
    Lee, K. K.
    Lee, S. J.
    Lee, J.
    Paik, S. W.
    Lim, H. Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [4] Nivolumab for hepatocellular carcinoma (HCC) in a real-world context.
    Rao, Nisha
    Rizk, Emanuelle M.
    Hwang, Regina
    Gartrell, Robyn Denise
    Makkar, Jasnit
    Oza, Jay
    Najjar, Marc
    Emond, Jean
    Fox, Alyson
    Verna, Elizabeth
    Brejt, Sidney
    Reis, Stephen
    Sheynzon, Vladimir
    Sperling, David
    Weintraub, Joshua
    Saenger, Yvonne M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] Real-world data of nivolumab in advanced hepatocellular carcinoma: A multi-centric and retrospective study
    Sardinha, M.
    Simao, D.
    Reis, A.
    Spencer, A.
    Parmanande, A.
    Saraiva, R.
    Calinas, F.
    Filipe, F.
    Winckler, P.
    da Luz, R.
    Martins, M.
    Gramaca, J.
    Ramos, M.
    Cadavez, E.
    Moura, M.
    Gil, L.
    Presa, J.
    Carrola, P.
    Pinho, I.
    Carvalho, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S127 - S127
  • [6] Immunotherapy with nivolumab after progression on lenvatinib in advanced hepatocellular carcinoma: A real-world Indian experience.
    Rauthan, Amit
    Patil, Poonam
    Murthy, Nitin Yashas
    Somashekhar, S. P.
    Zaveri, Shabber
    Aswath, Rajashri
    Prathyush, V.
    Jomi, Chinnu
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16117 - E16117
  • [7] Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience
    Wen-Chi Wu
    Tzu-Yuan Lin
    Ming‑Huang Chen
    Yi‑Ping Hung
    Chien-An Liu
    Rheun‑Chuan Lee
    Yi‑Hsiang Huang
    Yee Chao
    San-Chi Chen
    Investigational New Drugs, 2022, 40 : 789 - 797
  • [8] Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience
    Wu, Wen-Chi
    Lin, Tzu-Yuan
    Chen, Ming-Huang
    Hung, Yi-Ping
    Liu, Chien-An
    Lee, Rheun-Chuan
    Huang, Yi-Hsiang
    Chao, Yee
    Chen, San-Chi
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (04) : 789 - 797
  • [9] ALBI grade determines survival of nivolumab-treated patients with advanced hepatocellular carcinoma: a real-world observational study
    Lee, Pei-Chang
    Lee, ChiehJu
    Hou, Ming-Chih
    Chao, Yee
    Huang, Yi-Hsiang
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E606 - E606
  • [10] A Real-World Experience on a Chinese Population of Patients With Unresectable Hepatocellular Carcinoma Treated With Nivolumab
    Lee, Shou-Wu
    Yang, Sheng-Shun
    Lee, Teng-Yu
    GASTROENTEROLOGY RESEARCH, 2024, 17 (01) : 15 - 22
12345